Novel Myeloperoxidase Inhibitors for Treating Multiple Diseases.
Rachel MataPublished in: ACS medicinal chemistry letters (2024)
Provided herein are novel myeloperoxidase inhibitors, pharmaceutical compositions, use of such compounds in treating inflammatory, cardiovascular, respiratory, renal, hepatic, and neurological diseases, cancer, and neutrophilic-driven diseases, and processes for preparing such compounds.